Outcomes and treatment patterns of patients with primary mediastinal B‐cell lymphoma after CAR‐T cell therapy failure: A DESCAR‐T analysis

Documenti analoghi

• Outcomes of patients with relapsed or refractory primary mediastinal B‐cell lymphoma treated with anti‐CD19 CAR‐T cells: CARTHYM, a study from the French national DESCAR‐T registry
  di: Jean Galtier, et al.
  Pubblicazione: (2025)
• Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group
  di: Pierre Sesques, et al.
  Pubblicazione: (2026)
• Promoting and supporting leadership in hematology departments
  di: Roch Houot, et al.
  Pubblicazione: (2024)
• Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
  di: Amira Marouf, et al.
  Pubblicazione: (2025)
• In vivo CAR therapies: Turning the patient into their own CAR factory
  di: François Vilcot, et al.
  Pubblicazione: (2026)